Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation
Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation
Background
Bordetella pertussis
is among the leading causes of vaccine-preventable deaths and morbidity
globally. Human asymptomatic carriage as a reservoir for community
transmission of infections might be a target of future vaccine
strategies, but has not been demonstrated. Our objective was to
demonstrate that asymptomatic nasopharyngeal carriage of Bordetella pertussis is inducible in humans and to define the microbiological and immunological features of presymptomatic infection.Methods
Healthy
subjects aged 18–45 years with an antipertussis toxin immunoglobin G
(IgG) concentration of <20 international units/ml were inoculated
intranasally with nonattenuated, wild-type Bordetella pertussis
strain B1917. Safety, colonization, and shedding were monitored over 17
days in an inpatient facility. Colonization was assessed by culture and
quantitative polymerase chain reaction. Azithromycin was administered
from Day 14. The inoculum dose was escalated, aiming to colonize at
least 70% of participants. Immunological responses were measured.
Results
There were 34 participants challenged, in groups of 4 or 5. The dose was gradually escalated from 103 colony-forming units (0% colonized) to 105
colony-forming units (80% colonized). Minor symptoms were reported in a
minority of participants. Azithromycin eradicated colonization in 48
hours in 88% of colonized individuals. Antipertussis toxin IgG
seroconversion occurred in 9 out of 19 colonized participants and in
none of the participants who were not colonized. Nasal wash was a more
sensitive method to detect colonization than pernasal swabs. No shedding
of Bordetella pertussis was detected in systematically collected environmental samples.
Conclusions
Bordetella pertussis colonization can be deliberately induced and leads to a systemic immune response without causing pertussis symptoms.
Clinical Trials Registration NCT03751514.
403-411
de Graaf, Hans
fb174fd4-5130-4a17-88ca-832c150e94e7
Ibrahim, Muktar
92069adb-ce7d-4cb1-9491-c1c68bb5be19
Hill, Alison R
de7a9d4f-7c5c-440c-9619-5b390f6347fd
Gbesemete, Diane
45c5ae20-20f8-4bc0-b3cd-c9a102e94471
Vaughan, Andrew T
bfb2ceab-a592-457e-89f9-00fcd1dddbdb
Gorringe, Andrew
503cb828-4e75-44e9-a8af-61f814e02bc6
Preston, Andrew
f8d06589-7c45-4286-9abd-fc805bff2039
Buisman, Annemaire M
f182b980-b998-4417-b720-78c2a3e039a3
Faust, Saul
f97df780-9f9b-418e-b349-7adf63e150c1
Kester, Kent E.
dbd7d6c7-9cbd-4ce6-b628-200b9671ed43
Berbers, Guy
b75f6de3-9c7f-41bf-94ba-8ae0c5259829
Diavatopoulos, Dimitri A.
affbc396-d2f3-4edf-8907-04db507b01fd
Read, Robert
b5caca7b-0063-438a-b703-7ecbb6fc2b51
15 July 2020
de Graaf, Hans
fb174fd4-5130-4a17-88ca-832c150e94e7
Ibrahim, Muktar
92069adb-ce7d-4cb1-9491-c1c68bb5be19
Hill, Alison R
de7a9d4f-7c5c-440c-9619-5b390f6347fd
Gbesemete, Diane
45c5ae20-20f8-4bc0-b3cd-c9a102e94471
Vaughan, Andrew T
bfb2ceab-a592-457e-89f9-00fcd1dddbdb
Gorringe, Andrew
503cb828-4e75-44e9-a8af-61f814e02bc6
Preston, Andrew
f8d06589-7c45-4286-9abd-fc805bff2039
Buisman, Annemaire M
f182b980-b998-4417-b720-78c2a3e039a3
Faust, Saul
f97df780-9f9b-418e-b349-7adf63e150c1
Kester, Kent E.
dbd7d6c7-9cbd-4ce6-b628-200b9671ed43
Berbers, Guy
b75f6de3-9c7f-41bf-94ba-8ae0c5259829
Diavatopoulos, Dimitri A.
affbc396-d2f3-4edf-8907-04db507b01fd
Read, Robert
b5caca7b-0063-438a-b703-7ecbb6fc2b51
de Graaf, Hans, Ibrahim, Muktar, Hill, Alison R, Gbesemete, Diane, Vaughan, Andrew T, Gorringe, Andrew, Preston, Andrew, Buisman, Annemaire M, Faust, Saul, Kester, Kent E., Berbers, Guy, Diavatopoulos, Dimitri A. and Read, Robert
(2020)
Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation.
Clinical Infectious Diseases, 71 (2), .
(doi:10.1093/cid/ciz840).
Abstract
Background
Bordetella pertussis
is among the leading causes of vaccine-preventable deaths and morbidity
globally. Human asymptomatic carriage as a reservoir for community
transmission of infections might be a target of future vaccine
strategies, but has not been demonstrated. Our objective was to
demonstrate that asymptomatic nasopharyngeal carriage of Bordetella pertussis is inducible in humans and to define the microbiological and immunological features of presymptomatic infection.Methods
Healthy
subjects aged 18–45 years with an antipertussis toxin immunoglobin G
(IgG) concentration of <20 international units/ml were inoculated
intranasally with nonattenuated, wild-type Bordetella pertussis
strain B1917. Safety, colonization, and shedding were monitored over 17
days in an inpatient facility. Colonization was assessed by culture and
quantitative polymerase chain reaction. Azithromycin was administered
from Day 14. The inoculum dose was escalated, aiming to colonize at
least 70% of participants. Immunological responses were measured.
Results
There were 34 participants challenged, in groups of 4 or 5. The dose was gradually escalated from 103 colony-forming units (0% colonized) to 105
colony-forming units (80% colonized). Minor symptoms were reported in a
minority of participants. Azithromycin eradicated colonization in 48
hours in 88% of colonized individuals. Antipertussis toxin IgG
seroconversion occurred in 9 out of 19 colonized participants and in
none of the participants who were not colonized. Nasal wash was a more
sensitive method to detect colonization than pernasal swabs. No shedding
of Bordetella pertussis was detected in systematically collected environmental samples.
Conclusions
Bordetella pertussis colonization can be deliberately induced and leads to a systemic immune response without causing pertussis symptoms.
Clinical Trials Registration NCT03751514.
Text
ciz840
- Accepted Manuscript
Text
ciz840
- Version of Record
Text
deGraafCIDAcceptedmanuscript
- Other
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 22 August 2019
e-pub ahead of print date: 28 September 2019
Published date: 15 July 2020
Identifiers
Local EPrints ID: 434733
URI: http://eprints.soton.ac.uk/id/eprint/434733
ISSN: 1058-4838
PURE UUID: a6d38ffc-8921-4210-9b4b-000ad26e4448
Catalogue record
Date deposited: 07 Oct 2019 16:31
Last modified: 17 Mar 2024 03:06
Export record
Altmetrics
Contributors
Author:
Hans de Graaf
Author:
Muktar Ibrahim
Author:
Diane Gbesemete
Author:
Andrew T Vaughan
Author:
Andrew Gorringe
Author:
Andrew Preston
Author:
Annemaire M Buisman
Author:
Kent E. Kester
Author:
Guy Berbers
Author:
Dimitri A. Diavatopoulos
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics